Zelira Therapeutics Ltd
ZLD•Health Care•Biotechnology•Last updated: Dec 25
About
Zelira Therapeutics Ltd is a global biopharmaceutical company focused on developing clinically validated cannabinoid-based medicines. The company operates through two main segments: the development of proprietary cannabinoid formulations and the licensing of its intellectual property. Zelira's products target a range of therapeutic areas, including pain management, sleep disorders, and dermatology.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- ZLD
Related Shares
Investor Resources
Should you buy Zelira Therapeutics Ltd right now?
While ZLD looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now